Please login to the form below
FDA panel backs Takeda's inflammatory bowel disease drug
Vedolizumab on course for US approval to treat Crohn’s disease and ulcerative colitis
Sanofi's Aubagio backed by NICE
Oral MS drug recommended for NHS use in England and Wales
Novartis' Tasigna tops Glivec in long-term trial
Boost ahead of patent expiry for leukaemia drug
AZ donates Brixham lab to Plymouth University
Will create global research and education facility
Study highlights poor diabetes consultation
Less than a third of patients asked for input into their treatment plans
AZ wins EU approval for four-strain flu vaccine
Fluenz Tetra offers competition to GSK’s Influsplit Tetra/Fluarix Tetra
Auxilium's Xiaflex cleared in US for erection disorder
FDA approval to treat Peyronie's disease
Novartis myeloma drug clears phase III trial
Panobinostat on course to be first in new class of treatment for bone marrow cancer
Smart Glasses: A new look for healthcare?
Wearable computer devices like Google Glass are tipped to become the next big technology trend, and have exciting health applications
-
Counting what countsMeasurement is the lifeblood of communications and brand investment in analytics is poised for steep growth
-
Pharma should not ignore IndiaIt’s complicated, but multinational pharma cannot ignore a market with one billion plus people
-
European Court may yet force AbbVie and InterMune to release dataOrders rethink on EMA's Humira and Esbriet injunction
-
Pfizer ups the ante on clinical transparencyRevamps access to data portal
-
Lilly depression drug fails late-stage trialsWill not pursue edivoxetine as an add-on treatment for depression
-
NICE wants more info on Genzyme's MS drugUK health guidance body turns down Lemtrada in draft guidance
-
Pharma's return on R&D spend continues to slide And cost of launching new medicine rises to $1.3bn says report
-
IMS Health acquires HGS Europe
Founders Graeme and Angela McFarlane bring HGS' market access services to IMS' UK team
-
Teva expects big things from improved drug programmeAims to market enhanced versions of existing medicines
Latest appointments
-
ABPI names NHS partnership managerRaj Tugnet will lead work to strengthen pharma/NHS collaboration in UK
-
Senior hires at Precision Health MediaNew VP for ad sales, chief financial officer ad member of the board
-
Ketchum loses healthcare headAmanda Sefton leaves to pursue “passion project” in wine trade
-
MSD appoints new UK headMike Nally moves from Swedish division
-
Pfizer's Jonathan Emms to be ABPI presidentWill take over from MSD's Deepak Khanna in April
Featured jobs
- Global Brand Manager
- flexible salary + bonus + car allowance + benefits
- Brand Director - Highly Specialised Product - Global remit
- Highly Competitive Basic, Bonus + Benefits
- Commercial Manager
- Negotiable
- Regulatory Affairs Senior Manager, CMC - 12 month cotnract
- Competitive
Subscribe to our email news alerts
- ABPI names NHS partnership manager
- This month in 1901: The first Nobel Prize awards
- FDA panel backs Takeda's inflammatory bowel disease drug
- Representatives from Boehringer Ingelheim, Pfizer, UCB announced as judges for eyeforpharma Barcelona Awards
- Sanofi's Aubagio backed by NICE
- Novartis' Tasigna tops Glivec in long-term trial
PMHub
Aurora
Aurora is a multi-award winning healthcare marketing communications agency delivering proven results for clients...
Latest intelligence
- Doctors’ disease knowledge: an insight into Latin America
- A lack of specialists outside major cities means many major illnesses go undiagnosed...
- Survey: Digital Futures 2014
- Can you help us predict pharma's digital future?...
- Adherence to treatment and side effect management in breast cancer
- The success of treatment for breast cancer is dependent on a high level of adherence, however it is surprisingly common for women with breast cancer to miss doses or stop...
Quick links
